Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

[Diagnosing psychiatric disorders in people with (very) mild intellectual disabilities].

Wieland J, Kapitein S, Otter M, Baas RW.

Tijdschr Psychiatr. 2014;56(7):463-70. Dutch.

2.

Overexpression of chromosome 15q11-q13 gene products: a risk factor for schizophrenia and associated psychoses?

Boot E, Kant SG, Otter M, Cohen D, Nabanizadeh A, Baas RW.

Am J Psychiatry. 2012 Jan;169(1):96-7; author reply 97. doi: 10.1176/appi.ajp.2011.11091382. No abstract available.

PMID:
22223014
3.

Long-term outcome of bipolar depressed patients receiving lamotrigine as add-on to lithium with the possibility of the addition of paroxetine in nonresponders: a randomized, placebo-controlled trial with a novel design.

van der Loos ML, Mulder P, Hartong EG, Blom MB, Vergouwen AC, van Noorden MS, Timmermans MA, Vieta E, Nolen WA; LamLit Study Group.

Bipolar Disord. 2011 Feb;13(1):111-7. doi: 10.1111/j.1399-5618.2011.00887.x.

PMID:
21320258
4.

Efficacy and safety of two treatment algorithms in bipolar depression consisting of a combination of lithium, lamotrigine or placebo and paroxetine.

van der Loos ML, Mulder P, Hartong EG, Blom MB, Vergouwen AC, van Noorden MS, Timmermans MA, Vieta E, Nolen WA; LamLit Study Group.

Acta Psychiatr Scand. 2010 Sep;122(3):246-54. doi: 10.1111/j.1600-0447.2009.01537.x. Epub 2010 Feb 5.

PMID:
20136801
5.

Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial.

van der Loos ML, Mulder PG, Hartong EG, Blom MB, Vergouwen AC, de Keyzer HJ, Notten PJ, Luteijn ML, Timmermans MA, Vieta E, Nolen WA; LamLit Study Group.

J Clin Psychiatry. 2009 Feb;70(2):223-31. Epub 2008 Dec 30.

PMID:
19200421

Supplemental Content

Loading ...
Support Center